HomePFE • NYSE
Pfizer Inc
add
$23.29
2.27%
Pre-market:(0.52%)-0.12
$23.17
Closed: Aug 1, 7:40:39 AM UTC-4 · USD · NYSE · Disclaimer
Top news
Q2 earnings forecast for Pfizer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 13.72B | -7.82% |
Operating expense | 6.30B | -11.72% |
Net income | 2.97B | -4.75% |
Net profit margin | 21.63 | 3.30% |
Earnings per share | 0.92 | 12.20% |
EBITDA | 6.44B | -0.02% |
Effective tax rate | -6.79% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 17.32B | 45.18% |
Total assets | 208.03B | -5.91% |
Total liabilities | 117.39B | -8.67% |
Total equity | 90.64B | — |
Shares outstanding | 5.69B | — |
Price to book | 1.50 | — |
Return on assets | 5.72% | — |
Return on capital | 7.81% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | 2.97B | -4.75% |
Cash from operations | 2.34B | 114.22% |
Cash from investing | 3.27B | 89.03% |
Cash from financing | -5.23B | -6.00% |
Net change in cash | 374.00M | 117.50% |
Free cash flow | 1.47B | 283.84% |
Previous close
$23.83
Day range
$23.14 - $23.84
Year range
$20.92 - $31.32
Market cap
132.41B USD
Avg Volume
38.98M
P/E ratio
16.86
Dividend yield
7.39%
Primary exchange
NYSE
About
Founded
1849
Headquarters
Website
Employees
81,000